Orlova Yu. A.

TO THE QUESTION OF THE PATHOGENESIS OF SOME PRO-INFLAMMATORY AND IMMUNOLOGICAL LINKS OF THE ENDOMETRIOID DISEASE


About the author:

Orlova Yu. A.

Heading:

LITERATURE REVIEWS

Type of article:

Scentific article

Annotation:

The purpose of the literature review is to study the latest data on the pathogenetic links of chronic inflammation and disorders in the immune system in women with endometriosis. The diagnosis of endometriosis is now increasingly established in women of all ages. This trend has a poor prognosis, as already the total prevalence of endometrioid disease in women is 10%. It should be noted that the number of women of reproductive age with this pathology is increasing and according to various authors is in the range from 10 to 70%. Endometriosis poses a serious problem for normal functioning in various areas of the patient’s life and significantly impairs the quality of life. This is manifesting in the presence of pain, excessive menstrual bleeding and impaired reproductive potential, which is manifesting in primary and secondary infertility. However, in the presence of a wide variety of theories of the development of this pathology, including: implantation, genetic, hormonal, dysontogenetic, neoplastic, metaplastic, immune theories, etc., none of them fully describes the processes that lead to the development of endometriosis. However, many researchers recognize that endometriosis is a disease with aseptic chronic inflammation and significant impaired immune responses in these women. Implantation theory is that when the menstrual blood reverses through the fallopian tubes, the cells of the endometrium penetrate into the structures of the abdominal cavity due to their adhesive and invasive properties. However, retrograde menstruation is present in 90% of women, and endometriosis occurs in only 10% of women. Further, beyond the postulates of implantation theory, macrophages found in peritoneal fluid in 85% and in endometrial tissues of normal women increase in number and cause a whole pool of inflammatory reactions. Depending on the subspecies of M1 or M2 macrophages, they secrete a diverse number of cytokines and chemokines that, due to their functions, cause various processes in the abdomen and uterus. However, the role of the type of macrophage polarization in the genesis of endometrioid disease has not yet been fully identified, as some studies have shown an increase in the ratio of M2/M1 to M2 in endometrial cyst tissues and menstrual blood. In the endometrium of such women, the data regarding the type of polarization of macrophages differ. One source indicates a significant prevalence of M2 type, in others, the opposite of M1. Nowadays, it is known that chronic aseptic inflammation is maintained in endometrioid disease. Some literature data indicate that macrophage colony-stimulating factor (CSF-1) may be directly involved in this. It is responsible for the differentiation, proliferation and growth of macrophages. According to the literature, it is a predictor of oncogenicity in various gynecological diseases. CSF-1 increase in peritoneal fluid in women with endometriosis has also been observed. Breakdowns in the immune status, which is manifested not only in the altered immune response, but also in the evasion of endometrial cells by the destruction of NK cells eventually leads to impaired endometrial cells elimination processes and further disease progression. However, given that there are still unresolved questions about the direct involvement of macrophage polarization in the genesis of endometriosis and factors that contribute to the maintenance of chronic aseptic inflammation, this requires further study and detail to fully understand the pathogenetic patterns of endometrioid disease for implementation of necessary actions to improve diagnostic and treatment.

Tags:

endometriosis, macrophages, adenomyosis, infertility, pain syndrome

Bibliography:

  1. Zaporozhan VM, Tatarchuk TF, Kaminskyi VV, Boichuk AV, Bulavenko OV, Vdovychenko YuP, ta in. Natsionalnyi konsensus shchodo vedennia patsiientok iz endometriozom. Reproduktyvna endokrynolohiia. 2015 Ver;4(24):7-12. [in Ukrainian].
  2. Unanyan AL. Endometrioz i reproduktivnoe zdorov’ye zhenshchin. Akusherstvo, ginekologiya i reproduktsiya. 2010;4(3):6-11. [in Russian].
  3. Pshenichnyuk EYu, Asaturova AV, Adamyan LV, Zaytsev NV. Immunogistokhimicheskуie osobennosti eutopicheskogo i ektopicheskogo endometriya u patsientok s retsidiviruyushchim techeniem endometrioidnykh kist yaichnikov. Akusherstvo i ginekologiya. 2018;3:84-95. [in Russian].
  4. Veropotvelyan PN, Guzhevskaya IV, Veropotvelyan NP. Endometrioz u patsientok s otsrochennoy beremennost’yu, stradayushchikh besplodiem. Zdorov’ye zhenshchiny. 2012;5(71):155-9. [in Russian].
  5. Slesareva KV, Ermolova NV, Linde VA, Kolesnikova LV, Tomay LR. K voprosu o patogeneze naruzhnogo genіtal’nogo endometrioza. Zhurnal fundamental’noy meditsiny i biologii. 2013;1:18-22. [in Russian].
  6. Zaynetdinova LF, Telesheva LF, Shamaeva TN, Koryaushkina AV. Kliniko-anamnesticheskie osobennosti u zhenshchin s naruzhnym genital’nym endommetriozom. Chelovek. Sport. Meditsina. 2017;17(2):52-61. [in Russian].
  7. Pechenikova VA, Kostyuchek DF, Durasova EN. Kliniko-morfologicheskie i morfofunktsional’nye osobennosti endometrioza yaichnikov. Zhurnal akusherstva i zhenskikh bolеzney. 2010;LIX(5):110-7. [in Russian].
  8. Unanyan AL, Sidorova IS, Nikonets AD, Kostina YuV, Kuzenkova NN, Elisavetskaya AM, i dr. Dismenoreya, endometrioz, adenomioz: klinikopatogeneticheskie vzaimootnosheniya. Ginekologiya. 2018;20(1):9-15. [in Russian].
  9. Yarmolinskaya MI, Rusina EI, Khachaturyan AR, Florova MS. Klinika i diagnostika genital’nogo endometrioza. Zhurnal akusherstva i zhenskikh bolezney. 2016;LXV(5):4-21. [in Russian].
  10. Loginova ON, Sonova MM. Klinicheskie osobennosti naruzhnogo genital’nogo endometrioza. Akusherstvo, ginekologiya i reproduktsiya. 2011;5(3):5-9. [in Russian].
  11. Durasova EN, Kostyuchek DF, Pechenikova VA. Sravnitel’nyy analiz endommetrioza yaichnikov i kist yaichnikov neendometrioidnoy prirody. Zhurnal akusherstva i zhenskikh bolezney. 2011;LX(1):31-7. [in Russian].
  12. Unanyan AL, Sidorova IS. Differentsirovannyy podkhod k lecheniyu adenomioza. Akusherstvo, ginekologiya i reproduktsiya. 2011;5(2):16-20. [in Russian].
  13. Unanyan AL, Sidorova IS, Kogan EA. Aktivnyy i neaktivnyy adenomioz: kliniko-morfologicheskie varianty razvitiya, differentsirovannyy podkhod k terapii. 2012;6(2):25-30. [in Russian].
  14. Bichurina AS, Gushchin VA, Koryaushkina AV. Kliniko-anamnesticheskie osobennosti zhenshchin s genital’nym endometriozom. Zhurnal akusherstva i zhenskikh bolezney. 2017;LXVI(Spetsvypusk):100-1. [in Russian].
  15.  Padrul’ MM, Shirokina EV, Makhmudova SE. Problema diagnostiki endometrioza v ramkakh sistemnogo zabolevaniya. Permskiy meditsinskiy zhurnal. 2018;XXXV(1):21-6. [in Russian].
  16. Krasil’nikova AK, Malyshkina AI, Sotnikova NYu, Antsiferova YuS. Klinika «malykh» form endometrioza. Vestnik Ivanovskoy meditsinskoy akademii. 2018;23(3):18-21. [in Russian].
  17. Ermolova EV, Suturina LV, Labygina AV, Sharifullin MA, Sholokhov LF, Lazareva LM, i dr. Kliniko-gormonal’naya kharakteristika bol’nykh s endometrioz-assotsiirovannym besplodiem. Byulleten’ VSNTs SO RAMN. 2005;5(43):32-4. [in Russian].
  18. Gromova AM, Taranovska OO, Lihachov VK, Nesterenko LA, Martunenko VB. Suchasni aspektu likuvannya nepliddya, obumovlenogo endometriozom. Visnik problem biologiyi i meditsunu. 2009;4:73-5. [in Ukrainian].
  19. Ruzhenkov VA, Shvets KN. Mediko-psikhologicheskie kharakteristiki i psikhologicheskie rasstroystva pri genital’nom endometrioze (rasprostranennost’, klinika i terapiya). Nauchnye vedomosti BelGU. Ser.: Meditsina. Farmatsiya. 2016;35(19):23-9. [in Russian].
  20. Ishan-Khodzhaeva FR. Vliyanie kliniko-laboratornykh kharakteristik na psikhoemotsional’nyy status zhenshchin s endometriozom i besplodiem. Zhurnal akusherstva i zhenskikh bolezney. 2018;67(1):20-5. [in Russian].
  21. Linde VA, Tomay LR, Gun’ko VO, Pogorelova TN, Ermolova NV, Slesareva KV, i dr. Proteotomnye tekhnologii v izuchenii endometrioza. Meditsinskiy vestnik Yuga Rossii. 2013;4:12-6. [in Russian].
  22. Kononov AV, Mozgovoy SI, Mozgovaya EI, Novikov DG. Endometrioz: teorii proiskhozhdeniya. 2008;1(65):32-6. [in Russian].
  23. Hryshchenkо VI, Shcherbyna MO, redaktory. U 2 kn. Kn. 2: Ginekologiia: pidruchnyk. Kyiv: VSV «Medytsyna»; 2011. 376 s. + 8 s. kolor. Vkl [in Ukrainian].
  24. Pashkov VM, Lebedev VA. Sovremennye predstavleniya ob etiologii i patogeneza genital’nogo endometrioza. Voprosy ginekologii, akusherstva i perinatologii. 2007;6(3):52-61. [in Russian].
  25. Yang H, Zhou W, Chang K, Mei J, Huang L, Wang M. The crosstalk between endometrial stromal cells and macrophages impairs cytotoxicity of NK cells in endometriosis by secreting IL-10 and TGF-β. Reproduction. 2017;154(6):815-25.
  26. Lin YH, Chen YH, Chang HY, Au HK, Tzeng CR, Huang YH. Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies. Int J Mol Sci. 2018;19(8):2385.
  27.  Korchynska OO, Mashtepa AM, Voloshyna UV, Petrenko TH. Endometrioz yak odna iz suchasnykh problem u hinekolohii ta akusherstvi. Ukraina. Zdorovia natsii. 2015;2(34):104-15. [in Ukrainian].
  28. Solodovnikova NG, Niauri DA. Rol’ tsitokinov v razvitii naruzhnogo genital’nogo endometrioza. Vestnik Sankt-Peterburgkskogo universiteta. 2006;Ser.11(2):115-22. [in Russian].
  29. Gutikova LV, Pavlovskaya MA. Znachenie matriksnykh metalloproteinaz v patogeneze genital’nogo endometrioza. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta. 2016;4:43-9. [in Russian].
  30. Sokolov DI, Kondrat’yeva PG, Yarmolinskaya MI, Kramareva NL, Selyutin AV, Rulev VV, i dr. Soderzhanie khemokinov i tsitokinov v peritoneal’noy zhidkosti bol’nykh naruzhnym genital’nym endometriozom razlichnoy stepeni tyazhesti. Meditsinskaya immunologiya. 2007;9(1):85-90. [in Russian].
  31. Slavicheva OS, Bondarenko SA, Sulaeva ON. Rol’ makrofagov v razvitii bolevogo sindroma pri adenomioze. Ukrayns’kiy zhurnal meditsini, bіologіі ta sportu. 2015;2(2):192-5. [in Russian].
  32. Berbic M, Schulke L, Markham R, Tokushige N, Russell P, Fraser IS. Macrophage expression in endometrium of women with and without endometriosis. Human Reproduction. 2009;24(2):325-32.
  33. Slobodyanyuk BA, Popov AA, Chanturiya TZ, Manannikova TN, Machanskite OV, Fedorov AA, i dr. Immunologicheskie aspekty endometrioidnoy bolezni. Al’manakh klinicheskoy meditsiny. 2015;37:123-8. [in Russian].
  34. Herington JL, Bruner-Tran KL, Lucas JA, Osteen KG. Immune interactions in endometriosis. Expert Rev Clin Immunol. 2011;7(5):611-26.
  35. Chanturiya TZ. Rol’ immunologicheskikh faktorov pri razvitii razlichnykh form endometrioza. Aktual’nye problemy meditsiny i biologii. 2018;3:25-30. [in Russian].
  36. Conti P, DiGioacchino M. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc. 2001 May-Jun;22(3):133-7.
  37. Rath M, Müller I, Kropf P, Closs EI, Munder M. Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages. Front Immunol. 2014;5:532.
  38. Saqib U, Sarkar S, Suk K, Mohammad O, Baig MS, Savai R. Phytochemicals as modulators of M1-M2 macrophages in inflammation. Oncotarget. 2018;9(25):17937-50.
  39. Monastyrskaya EA, Lyamina SV, Malyshev IYu. M1 i M2 fenotipy aktivirovannykh makrofagov i ikh rol’ v immunnom otvete i patologii. Patogenez. 2008;6(4):31-9. [in Russian].
  40. Ponomarenko IV, Koneva OA, Altukhova OB. Molekulyarnye osnovy etiopatogeneza i kliniki endometrioza. Nauchnye vedomosti BelGU. Ser.: Meditsina. Farmatsiya. 2016;19(240),35:11-6. [in Russian].
  41. Podgaec S, Abrao MS, Dias JA, Rizzo LV, de Oliveira RM, Baracat EC. Endometriosis: an inflammatory disease with a Th2 immune response component. Human Reproduction. 2007 May;22(5):1373-9.
  42. Podgaec S, Junior AND, Chapron Ch, de Oliveira RM, Baracat EC, Abrão MS. Th1 and Th2 immune responses related to pelvic endometriosis. Revista da Associação Médica Brasileira. 2010;56(1):92-8.
  43. Capobianco A, Rovere-Querini P. Endometriosis, a disease of the macrophage. Front Immunol. 2013;4:9.
  44. Haslinda Yu, Sa’adi A, Hendarto H, Hoesin F. M1 M2 macrophage expression in menstrual blood flakes of women with endometriosis. Majalah Obstetri & Ginekologi. 2016;24(2):64-9.
  45. Ivanov IA, Tsiv’yan BL, Vologzhanin DA, Vardanyan SV, Orbeli MA, Repetun AN, i dr. Tsitokiny makrofagal’nogo zvena pri endometrioze. Tsitokiny i vospalenie. 2013;12(1-2):88-93. [in Russian].
  46. Wu J, Xie H, Yao S, Liang Y. Macrophage and nerve interaction in endometriosis. J Neuroinflammation. 2017;14(1):53.
  47. Matteo M, Cicinelli E, Neri M, Carrubba R, Carpagnano FA, Romeo F, et al. Pro-inflammatory M1/Th1 type immune network and increased expression of TSG-6 in the eutopic endometrium from women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2017 Nov;218:99-105.
  48.  Vallvé-Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with endometriosis. Human Reproduction Update. 2019;25(5):565-92.
  49. Pavlov RV, Sel’kov SA. Osobennosti populyatsionnogo sostava i funktsional’noy aktivnosti kletok peritoneal’noy zhidkosti u zhenshchin s naruzhnym genital’nym endometriozom. Zhurnal akusherstva i zhenskikh bolezney. 2008;LVII(3):67-71. [in Russian].
  50. Kocbek V, Vouk K, Bersinger NA, Mueller MD, Rižner TL. Panels of Cytokines and Other Secretory Proteins as Potential Biomarkers of Ovarian Endometriosis. The Journal of Molecular Diagnostics. 2015;17(3):325-34.
  51. Peng Y, Ma J, Lin J. Activation of the CXCL16/CXCR6 Axis by TNF-α Contributes to Ectopic Endometrial Stromal Cells Migration and Invasion. Reproductive Sciences. 2019;26(3):420-7.
  52. Suen JL, Chang Yu, Chiu PR, Hsieh TH, His E, Chen YuCh, et al. Serum Level of IL-10 Is Increased in Patients with Endometriosis, and IL-10 Promotes the Growth of Lesions in a Murine Model. The American Journal of Pathology. 2014;184(2):464-71.
  53. Yarmolinskaya MI, Molotkov AS, Denisova VM. Rol’ matriksnykh metalloproteinaz v patogeneze genital’nogo endometrioza. Zhurnal akusherstva i zhenskikh bolezney. 2012;LXI(2):92-100. [in Russian].
  54. Ahn SH, Monsanto SP, Miller C, Singh SS, Thomas R, Tayade C. Pathophysiology and Immune Dysfunction in Endometriosis. Biomed Res Int. 2015;2015:795976.
  55. Asghari S, Valizadeh A, Aghebati-Maleki L, Nouri M, Yousefi M. Endometriosis: Perspective, lights, and shadows of etiology. Biomed Pharmacother. 2018;106:163-74.
  56. Ziȩtec A, Futyma K, Nowakowski Ł, Gogacz M, Rechberger T. Progress on macrophage’s proinflammatory products as markers of acute endometriosis. Journal of Acute Disease. 2015;4(3):169-72.
  57. Zeyneloglu HB, Senturk LM, Seli E, Bahtiyar OM, Olive DL, Arici A. The peritoneal fluid levels of interleukin-12 in women with endometriosis. AJRJ. 1998;39:152-6.
  58. Nie MF, Xie Q, Wu YH, He H, Zou LJ, She XL, et al. Serum and Ectopic Endometrium from Women with Endometriosis Modulate Macrophage M1/M2 Polarization via the Smad2/Smad3 Pathway. J Immunol Res. 2018;2018:6285813.
  59. Sikora J, Ferrero S, Mielczarek-Palacz A, Kondera-Anasz Z. The Delicate Balance between the Good and the Bad IL-1 Proinflammatory Effects in Endometriosis. Current Medicinal Chemistry. 2018;25(18):2105-21.
  60. OuYang Z, Hirota Y, Osuga Y, Hamasaki K, Hasegawa A, Tajima T, et al. Interleukin-4 stimulates proliferation of endometriotic stromal cells. Am J Pathol. 2008;173(2):463-9.
  61. Miller JE, Monsanto SP, Ahn SH, Khalaj K, Fazleabas AT, Young SL, et al. Interleukin-33 modulates inflammation in endometriosis. Sci Rep. 2017;7(1):17903.
  62. Wu MH, Hsiao KY, Tsay SJ. Endometriosis and possible inflammation markers. Gynecology and minimally invasive therapy. 2015;4:61-7.
  63. Li S, Fu X, Wu T, Yang L, Hu C, Wu R. Role of Interleukin-6 and Its Receptor in Endometriosis. Med Sci Monit. 2017;23:3801-7.
  64. Malvezzi H, Hernandes C, Piccinato C, Podgaec S. Interleukin in endometriosis-associated infertility-pelvic pain: systematic review and metaanalysis. Reproduction. 2019;158(1):1-12.
  65.  Itoh H, Sashihara T, Hosono A, Kaminogawa S, Uchida M. Interleukin-12 inhibits development of ectopic endometriotic tissues in peritoneal cavity via activation of NK cells in a murine endometriosis model. Cytotechnology. 2011;63(2):133-41.
  66. Budrys NM, Nair HB, Liu YG, Kirma NB, Binkley PA, Kumar Sh, et al. Increased expression of macrophage colony-stimulating factor and its receptor in patients with endometriosis. Fertil Steril. 2012;97(5):1129-35.
  67. Aligeti S, Kirma NB, Binkley PA, Schenken RS, Tekmal RR. Colony-stimulating factor-1 exerts direct effects on the proliferation and invasiveness of endometrial epithelial cells. Fertil Steril. 2011;95(8):2464-6.
  68. Jones CV, Ricardo SD. Macrophages and CSF-1: implications for development and beyond. Organogenesis. 2013;9(4):249-60.

Publication of the article:

«Bulletin of problems biology and medicine» Issue 4 Part 1 (153), 2019 year, 38-43 pages, index UDK 618.14-002:612.017

DOI: